Document is current

Any future updates will be listed below

Comment on “Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration”

Crossref DOI link: https://doi.org/10.1007/s00417-024-06515-9

Published Online: 2024-06-07

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark